Repligen Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Repligen Stock Summary

Repligen competes with Avantor, Masimo, Baxter International, AptarGroup, and Bio Rad. Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. Repligen Corporation was incorporated in 1981 and is headquartered in Waltham, Massachusetts. Repligen operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 1852 people.

Repligen Key Financial Ratios

Repligen Key Balance Sheet Accounts

Repligen Key Income Statement Accounts

Repligen Key Cash Accounts

Repligen Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Repligen's current stock value. Our valuation model uses many indicators to compare Repligen value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Repligen competition to find correlations between indicators driving Repligen's intrinsic value. More Info.Repligen is rated fourth in return on equity category among its peers. It is rated fifth in return on asset category among its peers reporting about  14.44  of Return On Asset per Return On Equity. At this time, Repligen's Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Repligen's earnings, one of the primary drivers of an investment's value.

Repligen's Earnings Breakdown by Geography

Repligen Systematic Risk

Today, most investors in Repligen Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Repligen's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Repligen growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Repligen help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Repligen. We use our internally-developed statistical techniques to arrive at the intrinsic value of Repligen based on widely used predictive technical indicators. In general, we focus on analyzing Repligen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Repligen's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.